Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Perioperative Single Dose Systemic Dexamethasone for Postoperative Pain: A Meta-analysis of Randomized Controlled TrialsAnesthesiology (Philadelphia), 2011-09, Vol.115 (3), p.575-588 [Peer Reviewed Journal]2015 INIST-CNRS ;ISSN: 0003-3022 ;EISSN: 1528-1175 ;DOI: 10.1097/ALN.0b013e31822a24c2 ;PMID: 21799397 ;CODEN: ANESAVFull text available |
|
2 |
Material Type: Article
|
CORRIGENDUM FOR "Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone"The journal of clinical endocrinology and metabolism, 2018-02, Vol.103 (2), p.700-700 [Peer Reviewed Journal]Copyright © 2018 Endocrine Society ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2017-02651 ;PMID: 29420753Full text available |
|
3 |
Material Type: Article
|
Coronavirus breakthrough: dexamethasone is first drug shown to save livesNature (London), 2020-06, Vol.582 (7813), p.469-469 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-020-01824-5 ;PMID: 32546811Full text available |
|
4 |
Material Type: Article
|
Dexamethasone in Hospitalized Patients with Covid-19New England Journal of Medicine, 2021-02, Vol.384 (8), p.693-704 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2021436 ;PMID: 32678530Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Trial of Dexamethasone for Chronic Subdural HematomaThe New England journal of medicine, 2020-12, Vol.383 (27), p.2616-2627 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2020473 ;PMID: 33326713Full text available |
|
6 |
Material Type: Article
|
Authors' replyClinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10, p.1586 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;ISSN: 1177-5483 ;EISSN: 1177-5483Full text available |
|
7 |
Material Type: Article
|
Authors' replyClinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10, p.1586 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;ISSN: 1177-5483 ;EISSN: 1177-5483Full text available |
|
8 |
Material Type: Article
|
Authors' replyClinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10, p.1586 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;ISSN: 1177-5483 ;EISSN: 1177-5483Full text available |
|
9 |
Material Type: Article
|
Daratumumab plus Lenalidomide and Dexamethasone for Untreated MyelomaThe New England journal of medicine, 2019-05, Vol.380 (22), p.2104-2115 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1817249 ;PMID: 31141632Full text available |
|
10 |
Material Type: Article
|
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical TrialJAMA, 2020-10 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.17021Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized TrialJAMA : the journal of the American Medical Association, 2021-11, Vol.326 (18), p.1807 [Peer Reviewed Journal]ISSN: 1538-3598 ;EISSN: 1538-3598 ;DOI: 10.1001/jama.2021.18295Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trialThe lancet oncology, 2020-12, Vol.21 (12), p.1630-1642 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30525-8 ;PMID: 33129376Full text available |
|
13 |
Material Type: Article
|
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM studyBlood, 2012-08, Vol.120 (8), p.1589-1596 [Peer Reviewed Journal]2012 American Society of Hematology ;2015 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-02-408922 ;PMID: 22791289Full text available |
|
14 |
Material Type: Article
|
Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple MyelomaThe New England journal of medicine, 2019-08, Vol.381 (8), p.727-738 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1903455 ;PMID: 31433920Full text available |
|
15 |
Material Type: Article
|
Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaThe New England journal of medicine, 2022-07, Vol.387 (2), p.132-147 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2204925 ;PMID: 35660812Full text available |
|
16 |
Material Type: Article
|
Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trialOrphanet journal of rare diseases, 2014-01, Vol.9 (1), p.5-5, Article 5 [Peer Reviewed Journal]COPYRIGHT 2014 BioMed Central Ltd. ;COPYRIGHT 2014 BioMed Central Ltd. ;2014 Chessa et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2014 Chessa et al.; licensee BioMed Central Ltd. 2014 Chessa et al.; licensee BioMed Central Ltd. ;ISSN: 1750-1172 ;EISSN: 1750-1172 ;DOI: 10.1186/1750-1172-9-5 ;PMID: 24405665Full text available |
|
17 |
Material Type: Article
|
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre studyThe lancet oncology, 2016-01, Vol.17 (1), p.27-38 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 1, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(15)00464-7 ;PMID: 26671818Full text available |
|
18 |
Material Type: Article
|
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple MyelomaThe New England journal of medicine, 2015-01, Vol.372 (2), p.142-152 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1411321 ;PMID: 25482145Full text available |
|
19 |
Material Type: Article
|
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for MyelomaThe New England journal of medicine, 2017-04, Vol.376 (14), p.1311-1320 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1611750 ;PMID: 28379796Full text available |
|
20 |
Material Type: Article
|
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trialThe Lancet (British edition), 2020-11, Vol.396 (10262), p.1563-1573 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32292-3 ;PMID: 33189178Full text available |